Compare TNON & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNON | FLGC |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 7.6M |
| IPO Year | 2022 | 2021 |
| Metric | TNON | FLGC |
|---|---|---|
| Price | $1.11 | $9.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 125.7K | 16.1K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,233,000.00 | ★ $57,609,000.00 |
| Revenue This Year | $19.56 | N/A |
| Revenue Next Year | $71.06 | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.71 |
| 52 Week Low | $0.85 | $6.80 |
| 52 Week High | $5.85 | $81.90 |
| Indicator | TNON | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 46.42 |
| Support Level | $1.10 | $8.09 |
| Resistance Level | $1.15 | $13.70 |
| Average True Range (ATR) | 0.05 | 1.11 |
| MACD | 0.00 | 0.60 |
| Stochastic Oscillator | 62.50 | 34.80 |
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.